Mirum Pharmaceuticals, Inc. (MIRM)
NASDAQ: MIRM · Real-Time Price · USD
45.27
-0.30 (-0.66%)
May 13, 2025, 4:00 PM - Market closed
Mirum Pharmaceuticals Employees
Mirum Pharmaceuticals had 322 employees as of December 31, 2024. The number of employees increased by 58 or 21.97% compared to the previous year.
Employees
322
Change (1Y)
58
Growth (1Y)
21.97%
Revenue / Employee
$1,177,798
Profits / Employee
-$240,186
Market Cap
2.24B
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 94,300 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
MIRM News
- 4 days ago - Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Business Wire
- 5 days ago - Volixibat Data from Mirum's VANTAGE PBC Study Showcased at EASL - Business Wire
- 6 days ago - Mirum Pharmaceuticals, Inc. (MIRM) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 6 days ago - Mirum Pharmaceuticals Reports First Quarter 2025 Financial Results and Provides Business Update - Business Wire
- 9 days ago - Mirum Pharmaceuticals: A Respectable Liver, Rare Disease Franchise With Pipeline Opportunities - Seeking Alpha
- 14 days ago - Mirum Pharmaceuticals to Announce First Quarter 2025 Financial Results and Host Conference Call on May 7, 2025 - Business Wire
- 16 days ago - Mirum Pharmaceuticals to Present Data at Upcoming Medical Congresses - Business Wire
- 4 weeks ago - Mirum's LIVMARLI Now FDA Approved in Tablet Formulation - Business Wire